These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Halsey NA; Coberly JS; Desormeaux J; Losikoff P; Atkinson J; Moulton LH; Contave M; Johnson M; Davis H; Geiter L; Johnson E; Huebner R; Boulos R; Chaisson RE Lancet; 1998 Mar; 351(9105):786-92. PubMed ID: 9519950 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis. Chirehwa MT; McIlleron H; Rustomjee R; Mthiyane T; Onyebujoh P; Smith P; Denti P Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607022 [TBL] [Abstract][Full Text] [Related]
30. Venous leg ulcers. Nelson EA BMJ Clin Evid; 2011 Dec; 2011():. PubMed ID: 22189344 [TBL] [Abstract][Full Text] [Related]
38. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. Whalen CC; Johnson JL; Okwera A; Hom DL; Huebner R; Mugyenyi P; Mugerwa RD; Ellner JJ N Engl J Med; 1997 Sep; 337(12):801-8. PubMed ID: 9295239 [TBL] [Abstract][Full Text] [Related]